The groundbreaking therapy of the medication represents a significant development in the management of type 2 diabetes. Distinct from existing drugs, tirzepatide affects dual pathways – the GLP-1 hormone and GIP – https://tirzepatidepeptide521678.ja-blog.com/42399173/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment